Chemical genetic interactions elucidate pathways controlling tuberculosis antibiotic efficacy during infection

• 成果类型: Article
• 署名作者: Oluoch, Peter O.; Koh, Eun- Ik; Proulx, Megan K.; Reames, Charlotte J.; Papavinasasundaram, Kadamba G.; Murphy, Kenan C.; Zimmerman, Matthew D.; Dartois, Veronique; Sassetti, Christopher M.
• 署名单位: University of Massachusetts System; University of Massachusetts Worcester
• 刊物名称: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
• ISSN/ISSBN: 0027-12253
• DOI: 10.1073/pnas.241752512
• 发表日期: 2025-03-04
• 关键词: mycobacterium-tuberculosis; thiamine biosynthesis; resistance; bedaquiline; variants; enzyme; drugs; apba

摘要

Successful tuberculosis therapy requires treatment with an unwieldy multidrug combi- nation for several months. Thus, there is a growing need to identify novel genetic vul- nerabilities that can be leveraged to develop new, more effective antitubercular drugs. Consequently, recent efforts to optimize tuberculosis (TB) therapy have exploited Mycobacterium tuberculosis (Mtb) chemical genetics to identify pathways influencing antibiotic efficacy, novel mechanisms of antibiotic action, and new targets for TB drug discovery. However, the influence of the complex host environment on these inter- actions remains largely unknown, leaving the therapeutic potential of the identified targets unclear. In this study, we leveraged a library of conditional mutants targeting 467 essential Mtb genes to characterize the chemical-genetic interactions (CGIs) with TB drugs directly in the mouse infection model. We found that these in vivo CGIs differ significantly from those identified in vitro. Both drug- specific and drug- agnostic effects were identified, and many were preserved during treatment with a multidrug combination, suggesting numerous strategies for enhancing therapy. This work also elucidated the complex effects of pyrazinamide (PZA), a drug that relies on aspects of the infection environment for efficacy. Specifically, our work supports the importance of coenzyme A synthesis- inhibition during infection, as well as the antagonistic effect of iron limitation on PZA activity. In addition, we found that inhibition of thiamine and purine synthesis increases PZA efficacy, suggesting additional therapeutically exploitable metabolic dependencies. Our findings present a map of the unique in vivo CGIs, characterizing the mechanism of PZA activity in vivo and identifying potential targets for TB drug development.